Potent and selective CB2
receptor agonist (Ki
values are 22.7 nM and > 10 μ
M for CB2
receptors respectively, EC50
= 5.57 nM). Displays antiallodynic activity in the rat hindpaw incision model of postoperative pain. Also neuroprotective and improves motor performance in a mouse model of Huntington's Disease.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold under license from Hebrew University of Jerusalem
Cannabinoid CB2 receptor agonist activity in the hindpaw incision model of postoperative pain.
LaBuda et al.
HU-308: a specific agonist for CB2, a peripheral cannabinoid receptor.
Hanus et al.
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity.
Palazuelos et al.
The citations listed below are publications that use Tocris products. Selected citations for HU 308 include:
Showing Results 1 - 5 of 5